AIFF Stock Overview

A medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. More details

AIFF fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Revenue has declined by 84.6% over the past year

Makes less than USD$1m in revenue ($74K)

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($22M)

My Notes

Capture your thoughts, links and company narrative

Firefly Neuroscience, Inc. Competitors

VSee Health

NasdaqCM:VSEE

US$20.8m

DarioHealth

NasdaqCM:DRIO

US$23.9m

Streamline Health Solutions

NasdaqCM:STRM

US$14.1m

Bullfrog AI Holdings

NasdaqCM:BFRG

US$18.6m

Price History & Performance

Summary of share price highs, lows and changes for Firefly Neuroscience
Historical stock prices
Current Share Price	US$2.70
52 Week High	US$9.00
52 Week Low	US$2.31
Beta	0
1 Month Change	-10.00%
3 Month Change	-10.00%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-68.00%

Recent updates

Shareholder Returns

	AIFF	US Healthcare Services	US Market
7D	12.5%	1.2%	2.8%
1Y	n/a	-1.7%	24.5%

Return vs Industry: Insufficient data to determine how AIFF performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how AIFF performed against the US Market.

Price Volatility

Is AIFF's price volatile compared to industry and market?
AIFF volatility
AIFF Average Weekly Movement	20.5%
Healthcare Services Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.1%
10% least volatile stocks in US Market	3.1%

Stable Share Price: AIFF's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine AIFF's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	7	Jon Olsen	fireflyneuro.com

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners.

Firefly Neuroscience, Inc. Fundamentals Summary

How do Firefly Neuroscience's earnings and revenue compare to its market cap?
AIFF fundamental statistics
Market cap	US$21.60m
Earnings (TTM)	-US$7.75m
Revenue (TTM)	US$74.00k

310.3x

P/S Ratio

-3.0x

P/E Ratio

Is AIFF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AIFF income statement (TTM)
Revenue	US$74.00k
Cost of Revenue	US$0
Gross Profit	US$74.00k
Other Expenses	US$7.83m
Earnings	-US$7.75m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.91
Gross Margin	100.00%
Net Profit Margin	-10,475.68%
Debt/Equity Ratio	0%

How did AIFF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 02:35
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Firefly Neuroscience, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution